A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 8, 2021

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions

Hypertension

Interventions

DRUG

Telmione plus 80/12.5mg

Test drug (Fixed-dose combination drug of telmisartan 80mg and hydrochlorothiazide 12.5mg)

DRUG

Micardis plus 80/12.5mg

Reference drug (Fixed-dose combination drug of telmisartan 80mg and hydrochlorothiazide 12.5mg)

Trial Locations (1)

Chungbuk National University Hospital, Cheongju-si